Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Lisette Stork"'
Autor:
Noa Biran, Binod Dhakal, Suzanne Lentzsch, David Siegel, Saad Z. Usmani, Adriana Rossi, Cara Rosenbaum, Divaya Bhutani, David H. Vesole, Cesar Rodriguez, Ajay K. Nooka, Frits vanRhee, Lisette Stork‐Sloots, Femke deSnoo, Pritish K. Bhattacharyya, Durga Prasad Dash, Sena Zümrütçü, Martin H. vanVliet, Parameswaran Hari, Ruben Niesvizky
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 375-384 (2021)
Abstract Multiple myeloma (MM) is a heterogeneous hematologic malignancy associated with several risk factors including genetic aberrations which impact disease response and survival. Thorough risk classification is essential to select the best clini
Externí odkaz:
https://doaj.org/article/c560db62655e4754b5726b40b29caa1a
Autor:
Massimo Cristofanilli, Namita Chittoria, Sima Ehsani, Hallgeir Rui, Milana Dolezal, Lisette Stork-Sloots, Femke de Snoo, Christopher Recknor, Vandana Abramson
Publikováno v:
Cancer Research. 82:P5-17
Background C-C Chemokine Ligand type-5 (CCR5) is overexpressed in >95% of TNBC and has been correlated with disease progression. Moreover, enhancement of DNA repair signaling by CCR5 activation may contribute to chemotherapy resistance. Therefore, bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::819d3019609ef01e4bdc72aae25b341c
https://doi.org/10.1158/1538-7445.sabcs21-p5-17-08
https://doi.org/10.1158/1538-7445.sabcs21-p5-17-08
Autor:
Lisette Stork-Sloots, David S. Siegel, Martin H. van Vliet, David H. Vesole, Cara A. Rosenbaum, Femke A. de Snoo, Ajay K. Nooka, Durga Prasad Dash, Adriana C Rossi, Ruben Niesvizky, Parameswaran Hari, Cesar Rodriguez, Sena Zümrütçü, Frits van Rhee, Suzanne Lentzsch, Pritish K. Bhattacharyya, Binod Dhakal, Saad Z. Usmani, Divaya Bhutani, Noa Biran
Publikováno v:
eJHaem. 2:375-384
Multiple myeloma (MM) is a heterogeneous hematologic malignancy associated with several risk factors including genetic aberrations which impact disease response and survival. Thorough risk classification is essential to select the best clinical strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d420bd8ecc2f1f77b2ca569f92685dbb
https://doi.org/10.1002/jha2.209
https://doi.org/10.1002/jha2.209
Autor:
Noa Biran, Binod Dhakal, Suzanne Lentzsch, David Siegel, Saad Z. Usmani, Adriana Rossi, Cara Rosenbaum, Divaya Bhutani, David H. Vesole, Cesar Rodriguez, Ajay K. Nooka, Frits van Rhee, Lisette Stork-Sloots, Femke de Snoo, Pritish K. Bhattacharyya, DP Dash, Sena Zümrütçü, Martin van Vliet, Parameswaran Hari, Ruben Niesvizky
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::685ff6ad1892c0c06b93f4598c6e8115
https://doi.org/10.2139/ssrn.3689594
https://doi.org/10.2139/ssrn.3689594
Autor:
Fatima, Cardoso, Laura J, van't Veer, Jan, Bogaerts, Leen, Slaets, Giuseppe, Viale, Suzette, Delaloge, Jean-Yves, Pierga, Etienne, Brain, Sylvain, Causeret, Mauro, DeLorenzi, Annuska M, Glas, Vassilis, Golfinopoulos, Theodora, Goulioti, Susan, Knox, Erika, Matos, Bart, Meulemans, Peter A, Neijenhuis, Ulrike, Nitz, Rodolfo, Passalacqua, Peter, Ravdin, Isabel T, Rubio, Mahasti, Saghatchian, Tineke J, Smilde, Christos, Sotiriou, Lisette, Stork, Carolyn, Straehle, Geraldine, Thomas, Alastair M, Thompson, Jacobus M, van der Hoeven, Peter, Vuylsteke, René, Bernards, Konstantinos, Tryfonidis, Emiel, Rutgers, Martine, Piccart, Marc, Buyse
Publikováno v:
The New England journal of medicine, vol. 375, no. 8, pp. 717-729
BACKGROUND: The 70-gene signature test (MammaPrint) has been shown to improve prediction of clinical outcome in women with early-stage breast cancer. We sought to provide prospective evidence of the clinical utility of the addition of the 70-gene sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51178c2cd69f6819a624c99d576e33d5
https://doi.org/10.1056/nejmoa1602253
https://doi.org/10.1056/nejmoa1602253
Autor:
Peter D. Beitsch, Lisette Stork-Sloots, James Pellicane, Charles Nash, F de Snoo, Carrie L. Dul, P Baron, Paul Richards, Angela Mislowsky, Mary Murray, Stephanie Akbari, Mark A. Gittleman, Jennifer Beatty, P Whitworth, LL Lee, Michael Rotkis, Sarah Untch
Publikováno v:
Cancer Research. 76:P1-14
Background Ideally classification by subtype predicts treatment response and overall outcome. BluePrint 80-gene functional molecular subtype is based on mRNA expression (as is intrinsic subtype) associated with intact translation to protein (unlike i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4913aad11ed5d9f62fd9d43cfd7cf733
https://doi.org/10.1158/1538-7445.sabcs15-p1-14-05
https://doi.org/10.1158/1538-7445.sabcs15-p1-14-05
Autor:
B Peter, Lisette Stork-Sloots, F de Snoo, B Paul, B Jennifer, Angela Mislowsky, Stephanie Akbari, Mark A. Gittleman, Carrie L. Dul, Paul Richards, James Pellicane, Mary Murray, Charles Nash, Sarah Untch, W Pat, LL Lee, Michael Rotkis
Publikováno v:
Cancer Research. 76:P4-14
Background The prospective Neo-adjuvant Breast Registry Symphony Trial (NBRST) enrolled over 1000 US patients between June 2011 and December 2014. The aim of NBRST study is to compare chemosensitivity as defined by pathological Complete Response (pCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75031e7da0a174c6055d3c75c2696bb7
https://doi.org/10.1158/1538-7445.sabcs15-p4-14-10
https://doi.org/10.1158/1538-7445.sabcs15-p4-14-10
Autor:
Stephanie Akbari, James Pellicane, Paul Richards, Lisette Stork-Sloots, Mark A. Gittleman, LL Lee, Jennifer Beatty, F de Snoo, P Whitworth, Michael Rotkis, Angela Mislowsky, Charles Nash, P Baron, Mary Murray, Peter D. Beitsch, Sarah Untch, Carrie L. Dul
Publikováno v:
Cancer Research. 76:P4-14
Background The phase 4 Neo-adjuvant Breast Registry Symphony Trial (NBRST) enrolled over 1,000 US patients between June 2011 and December 2014. The aim of NBRST study is to compare chemo-sensitivity as defined by pathological Complete Response (pCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::864e3a57adf41c9ee014358adcf8a200
https://doi.org/10.1158/1538-7445.sabcs15-p4-14-29
https://doi.org/10.1158/1538-7445.sabcs15-p4-14-29
Autor:
Stephanie Akbari, Mark A. Gittleman, Charles Nash, Lisette Stork-Sloots, Sarah Untch, Peter D. Beitsch, Jennifer Beatty, Paul Richards, Mary Murray, Carrie L. Dul, James Pellicane, P Whitworth, Michael Rotkis, LL Lee, P Baron, F de Snoo, Angela Mislowsky
Publikováno v:
Cancer Research. 76:P3-07
Background Ideally classification by subtype predicts treatment response and overall outcome. BluePrint 80-gene functional molecular subtype is based on mRNA expression (as is intrinsic subtype) associated with intact translation to protein (unlike i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c79fe8e1a9681f102547052a555d0e27
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-67
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-67
Autor:
Martine Piccart-Gebhart, Lisette Stork-Sloots, Patrizia Dell'Orto, Giuseppe Viale, Femke A. de Snoo, Jan Bogaerts, Fatima Cardoso, Laura J van 't Veer, Jeroen van den Akker, Leila Russo, Emiel J. Th. Rutgers, Leen Slaets
Publikováno v:
Cancer Research. 75:P4-11
Background Biology has become the main driver of breast cancer (BC) therapy. Biological subtypes have been recommended as a guide for treatment selection. Molecularly identified subtypes can be determined by gene expression profiling. Alternatively,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a0907eb5d62c2ad933f9120de04bd26
https://doi.org/10.1158/1538-7445.sabcs14-p4-11-08
https://doi.org/10.1158/1538-7445.sabcs14-p4-11-08